Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Canagliflozin vs Pectin: Pectin has the stronger overall evidence (5.7 vs 4.5/10); they're alternatives for support heart health — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Pectin wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Too few graded studies
Top outcomes
Verdict
Too few graded studies
Top outcomes
Shared outcomes (1)
Outcomes where both Canagliflozin and Pectin have evidence — compare verdict strength side-by-side.
Off-label use mirrors diabetes dosing (e.g. 100–300 mg once daily before the first meal) under a clinician. A prescription drug; not an approved longevity regimen.
Morning
Oral tablet (canagliflozin)
6-15g of pectin daily, split across meals with water
With main meals, With a full glass of water, Split across the day (e.g. 2-3 doses)
Powder mixed in water or food
May add to glucose-lowering effect by slowing carbohydrate absorption; monitor
Discuss with your healthcare provider before combining.
Weeks
Unknown in humans
Months to years
Weeks to months
3-4 weeks
Same meal
30-120 minutes
First 1-2 weeks
Canagliflozin extends life span in genetically heterogeneous male but not female mice.
JCI insight (2020) · Animal
NIA Interventions Testing Program: canagliflozin extended lifespan in male mice
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
The New England journal of medicine (2015) · Rct · n=7020
EMPA-REG OUTCOME randomized trial (empagliflozin, same class)
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
The New England journal of medicine (2021) · Rct
EMPEROR-Preserved randomized trial (empagliflozin)
Cholesterol-lowering effects of dietary fiber: a meta-analysis
The American journal of clinical nutrition (1999) · Meta analysis
Meta-analysis of 67 controlled trials directly tested pectin, oat bran, guar gum, and psyllium against blood lipids.
Metabolic and Cardiovascular Benefits of Apple and Apple-Derived Products: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Frontiers in nutrition (2022) · Systematic review
Eighteen RCTs of whole apple, apple extract, and apple juice — key dietary sources of pectin — were pooled across nine cardiometabolic outcomes.
Systematic review of the mechanisms and evidence behind the hypocholesterolaemic effects of HPMC, pectin and chitosan in animal trials
Food chemistry (2016) · Systematic review
Systematic review of animal trials examining the cholesterol-lowering mechanisms of HPMC, pectin, and chitosan.
From a meta-analysis of 67 controlled trials of soluble fibres (PMID 9925120): across 2 to 10 g a day, each gram lowered total cholesterol by 0.045 mmol/L and LDL by 0.057 mmol/L, with pectin no different from oat or psyllium fibre, so 3 g is about 0.13 mmol/L and 10 g about 0.45 mmol/L of total cholesterol. The authors call the effect small within the practical range of intake. In healthy people with normal cholesterol, 12 g of pectin a day for 4 weeks did not change cholesterol (PMID 2992264). The relationship was modelled only up to 10 g.
AI-estimated from published studies. Interpret as directional guidance.
Pectin has a higher evidence score (5.7/10 vs 4.5/10) and wins in 2 of 3 categories.
For support heart health, Pectin has a higher relevance score (72 vs 70).
May add to glucose-lowering effect by slowing carbohydrate absorption; monitor Discuss with your healthcare provider before combining. Consult a healthcare provider for personalized advice.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.